LETC is an orally active alpha-synuclein (alpha-Syn) aggregation inhibitor with an EC50 of 66 nM in transfected DH60.21 neuroblastoma cells. LETC can cross the blood-brain barrier. LETC can be used for the study of synucleinopathies[1].
Molecular Weight:
414.44
Purity:
98.30
CAS Number:
[951131-13-8]
Formula:
C20H29Cl2N3S
Target:
alpha-synuclein
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted